Arterial Ulcer clinical trials at University of California Health

1 research study open to eligible people

Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers
open to eligible people ages 18 years and up
This study will assess the safety and efficacy of intramuscular injection of AMG0001 (hepatocyte growth factor [HGF] plasmid) to improve ulcer healing and perfusion in patients with peripheral artery disease.
at UCSF

Our lead scientists for Arterial Ulcer research studies include Michael S Conte, MD.

Last updated: December 2021

Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers